Treats T. vaginalis infection in females and males. ANDA 203458, held by Unichem Laboratories. Metronidazole.
As of Nov 21, 2026, ANDA 203458 (Metronidazole), held by Unichem Laboratories, was first approved by FDA on Jan 22, 2014, with 7 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Symptomatic Trichomoniasis. Metronidazole tablets are indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). Asymptomatic Trichomoniasis. Metronidazole tablets are indicated in the treatment of asymptomatic T. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. Since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 22, 2014 | Original application | Approved | None posted |
| Metronidazole250MG · tablet;oral | Metronidazole | Rx |
| Metronidazole500MG · tablet;oral | Metronidazole | Rx |
| Oct 25, 2024 | Supplement 25Labeling · Standard review | Approved | None posted |
| Jul 8, 2024 | Supplement 22Labeling · Standard review | Approved | None posted |
| Nov 22, 2023 | Supplement 19Labeling · Standard review | Approved | None posted |
| Mar 31, 2022 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 19, 2021 | Supplement 12Labeling · Standard review | Approved | None posted |
| Aug 14, 2019 | Supplement 6Labeling · Standard review | Approved | None posted |
| Aug 14, 2019 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jan 22, 2014 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters